Sitryx develops immunometabolic therapies for the treatment of cancer and autoimmune diseases.
Business Model:
Revenue: $1.3M
Employees: 11-50
Address: S10 Magdalen Centre Robert Robinson Avenue
City: Oxford
State: england
Zip: OX4 4GA
Country: GB
Sitryx develops immunometabolic therapies for the treatment of cancer and autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Corporate Round | 1 | $10M |
Eli Lilly Eli Lilly |
10/2018 | Series A | 4 | $30M |
GSK Longwood Fund Sofinnova Partners SV Health Investors GSK Longwood Fund Sofinnova Partners SV Health Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|